A New Strategy to Transform Liver Cancer Immunotherapy
December 7, 2021
UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.
Your search for “immunotherapy” returned 120 results
Inhibiting Enzyme Helps Cancer Immunotherapy Work Better
August 3, 2020
UC San Diego researchers discovered that people with an inactive RNA-editing enzyme respond better to cancer immunotherapy, and inhibitors of the enzyme help mice with difficult-to-treat cancers live longer.
10 Cancer Moonshot Blue Ribbon Panel Recommendations Embraced by NCI
September 7, 2016
When 28 distinguished individuals convened earlier this year to help shape the scientific mission at the National Cancer Institute (NCI) of Vice President Joe Biden’s National Cancer Moonshot Initiative, they were given five months to draft guidelines to accelerate cancer research, prevention and care. On Wednesday, the National Cancer Advisory…
Vaccine Targets Alzheimer’s Disease-like Characteristics in People with Down Syndrome
January 13, 2016
…Switzerland, will test the safety and tolerability of an immunotherapy vaccine that targets Alzheimer’s disease-like characteristics in adults with Down syndrome.
San Diego to be Research Hub for New Human Vaccines Project
April 7, 2016
The University of California, San Diego, J. Craig Venter Institute, La Jolla Institute for Allergy and Immunology and The Scripps Research Institute have teamed up to create the “Mesa Consortium,” a new scientific hub for the Human Vaccines Project. Under a collaborative agreement, the Mesa Consortium and the Human Vaccine…
Exploding Shells Boost Immune Response to Brain Cancer
September 17, 2019
Researchers at the University of California San Diego figured out a way to combine FDA-approved ultrasound with engineered glass particles to boost the effectiveness of immunotherapy in glioblastomas.
Researchers Develop a Remote-Controlled Cancer Immunotherapy System
January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.
How Ovarian Cancer Defies Immunotherapy
April 11, 2022
Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators, have further elucidated how ovarian cancer tumors defy immunotherapy, identifying new molecular targets that might boost immune response.
New Clinic Matches Patients with Cancer to Latest Precision Immunotherapy Treatments
October 17, 2019
New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.
Strauss Family Gives UC San Diego $1 Million to Help Develop a Cancer Vaccine
October 17, 2017
Iris and Matthew Strauss hold a great deal of respect for the doctors at Moores Cancer Center at UC San Diego Health. When their daughter’s cancer reappeared, it was the first place they turned for help. Because of their experience and trust in the medical and research staff, the couple…
